Hostname: page-component-cd9895bd7-fscjk Total loading time: 0 Render date: 2024-12-25T17:12:58.519Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuroleptic prescribing in an adolescent psychiatric in-patient unit

Published online by Cambridge University Press:  02 January 2018

K. Lowe ,
H. Smith  and
A. Clark
K. Lowe
Affiliation:
Queen Elizabeth Psychiatric Hospital, Birmingham
H. Smith
Affiliation:
Reaside Clinic, Birmingham
A. Clark*
Affiliation:
Regional Child and Adolescent Unit, 60 Queensbridge Road, Moseley, Birmingham B13 8QE
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Royal College of Psychiatrists' consensus statement suggests that prescribing high dose antipsychotic medication in children and adolescents should rarely be necessary. Our objective was to study the prescribing of antipsychotic medication in a regional adolescent unit during a three-year period. We found that antipsychotic prescribing on this unit is common in psychotic disorders and often high closes are required. This is not in keeping with the recommendations of the consensus statement. Review of clinical practice on other adolescent units is needed, together with a more comprehensive evaluation of the outcome of psychotic disorders in this age group.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 20 , Issue 9 , September 1996 , pp. 538 - 540
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 1996

References

British Medical Association & The Pharmaceutical Society (1995) British National Formulary, No 29. London: BMA & The Pharmaceutical Society.Google Scholar
Garralda, E. & Ainsworth, P. (1987) In Working with Troubled Adolescents (ed. Coleman, ), pp. 169–196. London: Academic Press.Google Scholar
Green, W. H., Padron-Gayol, M., Hardesty, A. S., et al (1992) Schizophrenia with childhood onset. Journal of the American Academy of Child and Adolescent Psychiatry, 31, 968–976.CrossRefGoogle ScholarPubMed
Thompson, C. (1994) The use of high-dose antipsychotic medication. British Journal of Psychiatry, 164, 448–458.CrossRefGoogle ScholarPubMed
Werry, J. S., McClellan, J. M. & Chard, L. (1991) Childhood and adolescent schizophrenia, bipolar, and schizoaffective disorders: a clinical and outcome study. Journal of American Academy of Child and Adolescent Psychiatry, 30, 457–465.CrossRefGoogle ScholarPubMed
Will, D., Wrate, R. M., Bhate, S., et al (1994) High dose anti-psychotic medication. British Journal of Psychiatry, 165, 269–270.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.